Salis, Zubeyir http://orcid.org/0000-0003-2982-4591
Sainsbury, Amanda
I. Keen, Helen
Gallego, Blanca
Jin, Xingzhong http://orcid.org/0000-0003-4293-8665
Article History
Received: 27 August 2021
Revised: 21 November 2021
Accepted: 26 November 2021
First Online: 11 January 2022
Competing interests
: ZS and AS own 50% each of the shares in Zuman International, which receives royalties for books AS has written and payments for presentations. AS additionally reports receiving presentation fees and travel reimbursements from Eli Lilly and Co, the Pharmacy Guild of Australia, Novo Nordisk, the Dietitians Association of Australia, Shoalhaven Family Medical Centres, the Pharmaceutical Society of Australia, and Metagenics, and serving on the NestleĢ Health Science Optifast VLCD advisory board from 2016 to 2018.